12:00 AM
 | 
Dec 07, 1998
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Vitrase enzyme injection: Advanced Corneal began U.S. Phase III testing in 800 patients

The product is approved in Mexico.

Advanced Corneal Systems Inc., Irvine, Calif.
Product: Vitrase enzyme injection
Indication: Clear vitreous hemorrhage ...

Read the full 98 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >